Vanessa Stadlbauer Selected Research

ornithylaspartate

2/2022	Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis.
3/2007	Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vanessa Stadlbauer Research Topics

Disease

21	Fibrosis (Cirrhosis) 06/2022 - 06/2007
14	Liver Diseases (Liver Disease) 06/2022 - 08/2005
14	Inflammation (Inflammations) 06/2022 - 07/2010
10	Liver Cirrhosis (Hepatic Cirrhosis) 02/2022 - 01/2008
7	Infections 06/2022 - 02/2012
7	Acute-On-Chronic Liver Failure 01/2020 - 01/2006
6	Liver Failure 01/2020 - 09/2005
5	Dysbiosis 06/2021 - 11/2017
5	Chronic Hepatitis C 01/2021 - 01/2006
5	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 11/2009
5	Acute Liver Failure (Fulminant Hepatic Failure) 01/2016 - 08/2005
4	Neoplasms (Cancer) 06/2022 - 05/2011
4	Body Weight (Weight, Body) 01/2022 - 11/2005
4	End Stage Liver Disease 01/2020 - 11/2009
4	Endotoxemia 10/2016 - 11/2007
3	Hepatic Encephalopathy 02/2022 - 03/2007
3	Ascites 01/2022 - 01/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2020
3	Hemorrhage 05/2021 - 01/2010
3	Malnutrition (Nutritional Deficiencies) 02/2021 - 01/2018
3	Chronic Renal Insufficiency 10/2016 - 12/2015
3	Brain Death (Brain Dead) 10/2013 - 04/2012
3	Ischemia 04/2013 - 10/2003
2	Hyponatremia 09/2022 - 05/2021
2	Disease Progression 06/2022 - 01/2020
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2006
2	Obesity 10/2021 - 01/2018
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 09/2021 - 06/2008
2	Hepatorenal Syndrome 05/2021 - 01/2008
2	Sepsis (Septicemia) 05/2021 - 11/2013
2	Portal Hypertension 05/2021 - 01/2009
2	Critical Illness (Critically Ill) 04/2021 - 09/2020
2	Sclerosing Cholangitis 04/2021 - 09/2020
2	Hepatitis C 01/2021 - 01/2016
2	Peritonitis 01/2019 - 07/2010
2	Non-alcoholic Fatty Liver Disease 01/2018 - 02/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2017 - 02/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 01/2015
2	Ventricular Fibrillation 04/2013 - 04/2012
2	Brain Edema (Cerebral Edema) 03/2012 - 06/2007
2	Coma (Comas) 03/2012 - 06/2007
2	Hyperammonemia 10/2008 - 06/2007
1	COVID-19 09/2022
1	Fever (Fevers) 09/2022
1	Dizziness (Lightheadedness) 09/2022
1	Inappropriate ADH Syndrome (SIADH) 09/2022
1	Thrombocytopenia (Thrombopenia) 09/2022
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Thrombosis (Thrombus) 09/2022
1	Chronic Hepatitis B 06/2022
1	Coinfection 06/2022
1	Hepatitis B 06/2022
1	Cystic Fibrosis (Mucoviscidosis) 06/2022

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 04/2021 - 09/2007
9	AlbuminsIBA 05/2021 - 07/2008
7	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 03/2007
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2021 - 01/2015
4	EndotoxinsIBA 01/2018 - 09/2007
4	AmmoniaIBA 03/2012 - 06/2007
4	CytokinesIBA 03/2012 - 01/2006
3	Proton Pump InhibitorsIBA 04/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 06/2007
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2006
3	CholesterolIBA 01/2020 - 09/2007
3	zonulinIBA 01/2019 - 01/2015
3	LipopolysaccharidesIBA 01/2019 - 06/2007
3	Ribavirin (Virazole)FDA LinkGeneric 11/2017 - 01/2006
3	salicylhydroxamic acid (SHAM)IBA 03/2012 - 06/2007
2	ornithylaspartateIBA 02/2022 - 03/2007
2	fibroblast growth factor 21IBA 09/2021 - 06/2018
2	Lipopolysaccharide ReceptorsIBA 02/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	PrebioticsIBA 10/2020 - 07/2020
2	C-Reactive ProteinIBA 01/2020 - 11/2017
2	HDL LipoproteinsIBA 01/2020 - 07/2016
2	Biological ProductsIBA 01/2019 - 07/2008
2	BilirubinIBA 05/2016 - 07/2008
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2012 - 01/2009
2	Lipoproteins (Lipoprotein)IBA 02/2012 - 01/2009
1	ChAdOx1 nCoV-19IBA 09/2022
1	Vasopressins (Vasopressin)IBA 09/2022
1	VaccinesIBA 09/2022
1	Immunoglobulins (Immunoglobulin)IBA 06/2022
1	hepatitis B hyperimmune globulinIBA 06/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 06/2022
1	LaxativesIBA 02/2022
1	Insulin (Novolin)FDA Link 01/2022

Therapy/Procedure

13	Therapeutics 06/2022 - 06/2006
8	Liver Transplantation 06/2022 - 11/2002
4	Critical Care (Surgical Intensive Care) 09/2022 - 02/2008
4	Artificial Liver (Bioartificial Liver) 01/2016 - 09/2005
3	Transplantation 06/2022 - 01/2016
3	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 03/2007
3	Ligation 05/2021 - 07/2010
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2017 - 10/2016
2	Radiofrequency Ablation 01/2016 - 03/2012
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2008 - 03/2007
1	Drug Tapering 01/2022
1	Caloric Restriction 01/2022